Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely

Status:
Recruiting

Trial end date:
2022-10-01

Target enrollment:

Participant gender:

Induction and support of lactation in women with preterm delivery and inadequate milk production.

Phase 2

Ferring Pharmaceuticals